Pediatric Psychopharmacology

Credit

Handouts

Speaker

David Dadiomov, PharmD, BCPP Related seminars and products

---

David Dadiomov, PharmD, BCPP, is an assistant professor of clinical pharmacy in the Titus Family Department of Clinical Pharmacy at the USC Mann School of Pharmacy and Pharmaceutical Sciences.

He holds board certification in psychiatric pharmacy and serves as the director of the PGY2 Psychiatric Pharmacy Residency Program. He has led, co-led and conducted extensive research on opioid use disorders among vulnerable populations, prevalence and distribution of high-risk prescription opioid use, therapeutic drug monitoring, treatment-resistant psychiatric conditions and more. Dr. Dadiomov practices as a clinical pharmacy specialist in addiction and psychiatry at the Complex Care Clinic of the Los Angeles County Department of Health Services, one of the largest of its kind in the United States.

Dr. Dadiomov’s teaching approach is case focused, practical for any clinical setting, interactive and evidence supported. His expertise has been shared with experienced clinicians, graduate students and advanced level students. Dr. Dadiomov is the recipient of multiple awards for clinical excellence, teaching and clinical innovation and has presented, authored and co-authored multiple peer-reviewed journal articles, book chapters, and scientific presentations.

 

Speaker Disclosures:
Financial: Dr. David Dadiomov has employment relationships with the University of Southern California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, University of Southern California Psychiatry and behavioral Sciences Medical Residency, and the Los Angeles County Department of Health Services. He previously received a speaking honorarium from Eli Lilly. Dr. Dadiomov receives grants from the 2024 SC CTSI Standard Pilot Grand Program, the USC Good Neighbors Grant Program, the Southern California Clinical and Translational Sciences Institute, and the Foundation for Opioid Response Efforts. He receives a speaking honorarium and recording royalties from Psychotherapy Networker and PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. David Dadiomov is a member of the American Society of Addiction Medicine, the American Association of Psychiatric Pharmacists, the American College of Clinical Pharmacy, and the American Society of Health-System Pharmacists. He is a reviewer for several publications, for a complete list contact PESI.com.

Additional Info

Program Information

Access never expires for this product.

For a more detailed outline that includes times or durations of time, if needed, please contact cepesi@pesi.com

Objectives

1. Identify common concerns relating to medications and their impact on function for children and teens with mental health disorders.  
2. Determine the role of professionals on the care team for clients who receive both psychotherapeutic medications and psychotherapy.  
3. Identify ethical issues related to communicating with clients and prescribing professionals.  
4. Determine the potential impact of medications on neurological development and function.  
5. Categorize the major classes of drugs used to treat mental disorders to improve health management. 
6. Identify adverse effects and drug reactions of the commonly prescribed psychotropic medications. 

Outline

Meds and Kids

• What you need to know about psychiatric medications
• Ethics guidelines
• Top tips for talking with kids about their medications
• Anticipate and address parents’ concerns
• Coordinating care: prescriber, therapist, parents, school
• Risks of off-label use and safety indications
• Limitations of the research and potential risks

The Developing Nervous System

• Organization of the nervous system
• Communication between neurons
• How medicines act differently in children
• Genetics and environment impact
• Potential impact of meds on neurological development

Depression, Anxiety, and Related Disorders

• Differential pediatric diagnosis and the DSM-5®
• SSRIs, SNRIs, Benzodiazepines
• Benefits and adverse reactions in youth
• Powerful combination: CBT + meds
• Address concerns related to suicide risk with SSRIs
• OCD treatment approaches
• Case Study

Trauma and Adverse Childhood Experiences

• Comorbid conditions in kids
• Neurodevelopmental impact
• Medications that can worsen PTSD outcomes
• SSRIs for trauma
• Case study

Behavior Disorder Medications

• Monotherapy: pros and cons
• Oppositional Defiant Disorder, Conduct Disorder, and Disruptive Mood Dysregulation Disorder
• Lithium, anticonvulsants, and 2nd generation antipsychotics
• Efficacy and side effects
• Tips to increase medication compliance
• Case study

ADHD Medications

• Neurobiology and subtypes
• Methylphenidate and amphetamine
• Immediate vs extended release
• Medication consistency and compliance: working with the school team
• Addressing common parent concerns
• Case study

Antipsychotic Medications

• Psychosis symptoms in kids and teens
• 1st and 2nd generation antipsychotics
• Mechanism of action
• Benefits and adverse reactions
• Case study

Autism Spectrum Disorder

• Brain differences in ASD
• Co-occurring behaviors and conditions
• Medications for autism-related behaviors
• Efficacy and side effects
• Case study

Other Neurodevelopmental Disorders

• Tic disorders/Tourettes
• Genetic disorders
  • Down Syndrome
  • Fragile X Syndrome
  • Klinfelter’s Syndrome
  • Prader-Willi Syndrome
• Pharmacologic treatments

Eating Disorders

• Anorexia Nervosa, Bulimia Nervosa, Binge Eating Disorder
• Neurobiology and pharmacologic treatments
• Benefits and adverse reactions
• Case study

Substance Use Disorders

• Overview of drugs of misuse
• Adverse effects and outcomes of using substances in adolescence
• Harm reduction in substance use
• Treatment of addiction disorders
  • Opioids (including fentanyl and counterfeit pills)
  • Marijuana
  • Stimulants (cocaine, methamphetamine)
  • Alcohol
  • Tobacco/vaping

Target Audience

• Counselors
• Social Workers
• Psychologists
• Psychotherapists
• Case Managers
• Nurse Practitioners
• Physician Assistants
• Art Therapists
• Occupational Therapists
• Physicians
• Addiction Counselors
• Other Mental Health & Health Care Professionals